Loading organizations...
§ Private Profile · New York City, NY, USA
Parsley Health is a technology company.
Parsley Health operates as a functional medicine company, delivering a comprehensive, root-cause approach to healthcare. It offers personalized care plans, advanced diagnostic lab testing, and clinician-led virtual consultations that integrate both conventional and functional medical methodologies. The company's core offerings include a Complete Care program for ongoing health management and Longevity Labs for proactive health optimization and early intervention.
The company was founded in 2016 by Dr. Robin Berzin, a physician and graduate of Columbia University College of Physicians and Surgeons. Her founding insight emerged from observing patients with persistent symptoms who found little resolution within traditional medical frameworks. Dr. Berzin recognized a gap in care where deeper investigation into underlying causes was needed, inspiring her to build a practice that systematically applied functional medicine principles.
Parsley Health primarily serves individuals seeking to address chronic conditions, optimize their well-being, and gain a deeper understanding of their health. Customers include those struggling with gut health issues, hormonal imbalances, autoimmune conditions, and mental health challenges. The company's vision is to empower people to resolve their underlying symptoms and achieve lasting vitality by taking control of their health through a deeply personalized and evidence-based medical approach.
Parsley Health has raised $36.0M across 2 funding rounds.
Parsley Health has raised $36.0M in total across 2 funding rounds.
Parsley Health is a digital health company founded in 2016 that delivers personalized, functional medicine through a virtual-first platform combining telemedicine, advanced diagnostics, nutrition, wellness, and conventional care.[1][2][5] It serves patients nationwide with chronic conditions, offering root-cause treatment via board-certified doctors, health coaches, and holistic plans, addressing issues like hormones, fertility, mental health, autoimmune disorders, and metabolism.[2][4][6] The company solves the limitations of traditional reactive healthcare by focusing on underlying causes, achieving symptom improvement for 89% of patients in the first year and a 32% reduction in total care costs.[4][5]
With hybrid operations from its New York HQ and centers in NYC and LA, Parsley blends tech (e.g., Golang, React, PostgreSQL) with in-person and remote services, expanding via insurance coverage for 10M+ lives and employer partnerships growing 250% YoY.[1][2][4]
Parsley Health was founded in 2016 by Dr. Robin Berzin, inspired by her grandmother's chronic illness and her own experiences during training at Columbia and Mount Sinai, where she identified gaps in treating chronic conditions through root-cause medicine rather than reactive prescriptions.[1][4] Berzin launched the company to create a tech-enabled service blending functional medicine, advanced testing, and holistic care to reverse chronic diseases driving 80% of U.S. healthcare costs.[4]
Early traction came from brick-and-mortar centers in NYC and LA, followed by a pivotal $26M Series B funding round that enabled nationwide telemedicine membership, at-home diagnostics like Comprehensive Hormone Care, and expansion plans to 50 states.[3] This shift to digital services marked a key evolution, making root-cause care accessible remotely while hiring more doctors and scaling employer contracts.[3][4]
Parsley rides the functional medicine and telehealth boom, targeting chronic diseases amid rising U.S. healthcare costs, where root-cause approaches counter the "revolving door" of prescriptions and specialists.[3][4] Timing aligns with post-pandemic virtual care adoption, insurance shifts toward value-based models, and demand for personalized wellness in hormones, fertility, and mental health—areas underserved by conventional systems.[2][4][6]
Market forces like self-insured employer growth (250% YoY for Parsley) and tech integration (e.g., AI-adjacent diagnostics) favor its model, positioning it as a "super solution" for complex needs.[4] As a 2021 World Economic Forum Technology Pioneer, Parsley influences the ecosystem by validating holistic digital health, lowering costs, and scaling prevention to reduce the $4T+ chronic care burden.[4][7]
Parsley Health is poised to dominate virtual functional medicine by tripling employer partnerships, launching more diagnostics, and deepening value-based contracts amid aging populations and midlife health trends.[4][6] Trends like AI-driven personalization, expanded insurance, and proactive care for perimenopause/fertility will accelerate growth, potentially capturing more of the 10M+ covered lives.[2][3]
Its influence may evolve from niche pioneer to mainstream integrator, blending tech and holistic care to redefine chronic disease management—proving that accessible root-cause medicine can thrive in a fragmented healthcare landscape, much like its founding vision to fix a broken system.[4]
Parsley Health has raised $36.0M in total across 2 funding rounds.
Parsley Health's investors include Eric Martineau-Fortin, Addition, Alumni Ventures, Arkitekt Ventures, Curie.Bio, Curious Capital, Jenny Fielding, FirstMark Capital, Great Oaks Venture Capital, KRM Interests LLC, Operator Partners, Pareto Holdings.
Parsley Health has raised $36.0M across 2 funding rounds. Most recently, it raised $26.0M Series B in October 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 1, 2019 | $26M Series B | Eric Martineau Fortin | Addition, Alumni Ventures, Arkitekt Ventures, Curie.bio, Curious Capital, Jenny Fielding, FirstMark Capital, Great Oaks Venture Capital, KRM Interests LLC, Operator Partners, Pareto Holdings, Thirty Five Ventures, Thrive Capital, WGI Group, Alain Hanover, Alex Pattis, Derrick LI, Neil Parikh, NAT Turner, TOM X LEE, Alpha Edison, Amplo, Galaxy Digital, TMV | Announced |
| Apr 1, 2018 | $10M Series A | FirstMark Capital | Addition, Arkitekt Ventures, Curie.bio, Curious Capital, Jenny Fielding, Great Oaks Venture Capital, KRM Interests LLC, Operator Partners, Pareto Holdings, Techstars, UpHonest Capital, WGI Group, Derrick LI, Neil Parikh, Wayne Chang, Dave Gilboa, Mark Hyman, MD, NAT Turner, Amplo, Combine, TCG (The Chernin Group), TMV | Announced |